Mr Sashi Kommu

Honorary Reader in Uro-oncology and Cancer Biology
Consultant Pelvic Cancer Urological Surgeon: EKHUFT
NIHR Clinical Research Network Surgical Specialty Lead: KSS

About

Mr Sashi Kommu is Honorary Reader in Uro-oncology and Cancer Biology at University of Kent. He is also Consultant Pelvic Cancer Urological Surgeon with a Subspecialty interest in minimally invasive management of urological cancers including laparoscopic and robotic urological surgery at East Kent Hospitals University NHS Foundation Trust. He leads The National Institute for Health Research (NIHR) for all Surgical Specialties for Kent, Surrey and Sussex.
He completed his Basic Surgical Training in the North West in England and Higher Surgical Training as a Specialist Registrar/ Urology Resident in the London Deanery in the United Kingdom.
His academic interests are both clinical and basic sciences. His key clinical interests are in the minimally invasive management of urological cancers, surgical robotics and intelligent probes. He has done formal research at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research with The Translational Cancer Genetics Team where he refined his scientific methodology in advanced labarotory work with an emphasis on cancer genetics and proteomics. He has also gained vast exposure in Nanotechnology. He has over 100 peer-reviewed publications in respected scientific and medical journals including The Lancet. He also has over 300 Scientific Presentations, several book chapters and books. Mr Kommu has over 25 academic awards including The Olympus Award at The 25th World Congress of Endourology in Cleveland U.S.A. 2006. He has nine patents pending including, a cost effective Telerounding Kit for Remote Teleconsultations, which was presented at The House of Commons (Hosted by The British Parliament) in 2006. His ability to blend medical science with engineering and technology has earned him two NASA collaborative scientific commendations. Dr Kommu is reviewer for 15 Surgical/Urological and 3 Basic Sciences Journals. Among several novel concepts described by Dr Kommu, include ‘suppressor screening in urological cancer screening’ and ‘the supplementary biomarker approach’ for detecting cancers. 

ORCID ID:0000-0003-4257-2157

Research interests

Areas of Clinical Expertise:

Main Areas of Expertise: Endourology and the diagnosis and management of benign and malignant prostatic diseases, robot assisted radical prostatectomy, robotic assisted radical cystectomy and ileal conduit.
Main Areas of Research: Focused on Biosciences Laboratory Work, Simulation Laboratory Work, Surgical Outcomes, Artificial Intelligence and Health Technology Innovation. All themes are centred on early detection of cancers and improving patient outcomes.
Bioscience Laboratory Based Research
The investigation and development of new tools to help in the surgical management of urological cancers including the use of intelligent probes.
The improvement of Health Care Delivery including Enhanced Recovery after Robotic Cystectomy and Ilea Conduit/Neobladder.
Laboratory interest is focused on the development and testing of new and existing methods for predicting the aggressiveness of prostate and bladder cancer.
The identification of new serum and urine based tests and the basic science investigation of new biomarkers for the detection and prediction progression of urological malignancies.
The early detection of urological malignancies through genomics, tissue microarray and proteomics.
Theranostics in urological malignancies.
Real-Time Multiple Microsensor Tissue Recognition and Mass Spectroscopy in the detection of solid cancers.
   
Simulation Laboratory Based Research – Surgical Skills Acquisition & Delivery 1. MEDUSA Study - Medical Education in Diseases of Urology a Signatured Approach. (Prostate cancer). MEDUSA-P 2. STANDRED-P Study – STANdardisation of Digital Rectal Examination Description for Prostate
Surgical Outcomes Based Research 1. SenASim Study - Sensory Acquaintance Simulation during Postoperative Period 2. ASOCAP - Alliance for Studies on Outcomes in CArcinoma Prostate after Robotic Surgery 3. NACEPA Trial - NAtional (Cystectomy Enhanced Preparation, Event and Recovery) CEPER PAthway Trial 4. SPARTACUS Prostate Pathway - Streamlined Pathway for Rapid Testing And Curative Urological Surgery 5. POSEIDON Study - Psychosocial Optimisation in Surgical patients through Edified Intelligence Delivery, Orientation and Nurturing 6. SUROP (Suspension of Urethra in RObotic Prostatectomy) Trial - A Randomised Controlled Trial of Impact of Urethral Suspension on Continence 7. SAGARP Trial - Randomized Control Trial of Spinal And General Anaesthetic in Robotic Prostatectomy
  
Health Technology Innovation 1. CoBoSo Study – Continuous Bowel Sound Monitoring following major bowel surgery 2. EWAROC Study - Early WArning scoring system post RObotic Cystectomy 
3. ENSUDI Trial - ENdoscopic SUbmucosal DIssection for low grade Bladder Cancer An ex-vivo laboratory based study 

Artificial Intelligence in Healthcare Mucosal Composite of Bladder Cancer Study [MUCOMB Cancer Study] Group: Biosciences/ (Uro-oncology) / Forensics Academic Supervisory Team: Mr Sashi Kommu Co-supervisor: Dr Stuart Gibson (School of Physical Sciences) Laboratory supervisor: Stuart Gibson
Primary Outcome Measures To determine the overall sensitivity and specificity of detecting bladder cancer or suspicious mucosal lesions. 

Secondary Outcome Measures To compare the overall utility of the proposed platform with conventional diagnostic tools.
MUSTANG - B Study – MUcosal Study of Terrain using Artificial intelligence and Neural network Gating – Bladder Cancer Academic Supervisory Team: Mr Sashi Kommu 
Co-supervisor: Dr Stuart Gibson (School of Physical Sciences) 
Laboratory supervisor: Stuart Gibson 

AIDMR Study - Standardised Scoring System using AI Decision Tree Algorithms for mpMRI Prostate Reporting Academic Supervisory Team: Mr Sashi Kommu
Co-supervisor: Dr Stuart Gibson (School of Physical Sciences)
Laboratory supervisor: Stuart Gibson 

Teaching

Organises educational visits to the Urology Unit at Kent and Canterbury hospital during enhancement weeks for MSc-T and BSc Biomedicine students. Visits include talks from surgeons, pathologists, oncologists and specialist nurses and the students observe cancer surgeries via live-link to the operating theatres. 

Undergraduate Teaching: Enhancement weeks for MSc-T and BSc Biomedicine students PaCES Programme
Postgraduate Teaching: BI857 - Cancer Research in Focus
Biology of Cancer Series - Urology Grand Rounds Virtual Teaching 
Biology of Urological Cancers - Urology Grand Rounds Virtual Teaching   

Supervision

PhD Artificial Intelligence 

  • MUCOMB Cancer Study Mucosal Composite of Bladder Cancer Study

MS Uro-oncology 1

  • NACEPA Trial - NAtional CEPER PAthway Trial 

MS Uro-oncology 2 

  • POSEIDON Study - Psychosocial Optimisation in Surgical patients through Edified Intelligence Delivery, Orientation and Nurturing

MD

  •  CoBoSo Study – Continuous Bowel Sound Monitoring following major bowel surgery 
  • EWAROC Study - Early WArning scoring system post RObotic Cystectomy  

Professional

  1. British Association of Urological Surgeons. Section of Oncology. 
  2. British Association of Urological Surgeons. BAUS Section of Endourology. 
  3. The Royal College of Surgeons of Edinburgh.  
  4. The Royal College of Surgeons of England. 
  5. The British Medical Association. 
  6. The Endourological Society. 
  7. Society of Robotic Surgery (Invited 2010). 
  8. SCIYO – Scientific Advisory Board.
  9. European Association of Urology 
  10. National Institute for Health Research.
Last updated